---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-164532"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:10:17.778070+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine shareholders elect directors, ratify auditor at 2023 annual meeting

## Summary
- Elected Georges Gemayel, Mark Chin, and Liam Ratcliffe as Class II directors for two-year term ending 2025.
- Elected Donald Nicholson, William White, and John Quisel as Class III directors for three-year term ending 2026.
- Ratified Ernst & Young as independent auditor for fiscal year ending December 31, 2023.
- All director nominees received substantial majority of votes cast; broker non-votes ~980k.

## SEC filing metadata
- accession: 0001193125-23-164532
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/0001193125-23-164532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/d477797d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-164532
- JSON: https://secwatch.observer/filing/0001193125-23-164532.json
- Plain text: https://secwatch.observer/filing/0001193125-23-164532.txt

## Key facts
- Shareholder Votes
  Disc Medicine, Inc. shareholders approved Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm at the 2023-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-09
  source text: Proposal 2 – Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the stockholders’ vote with respect to such ratification were as follows: Votes For Votes Against Abstain 13,678,267 18,084 373,951
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/0001193125-23-164532-index.htm
- Shareholder Votes
  Disc Medicine, Inc. shareholders approved Election of Class II and Class III Director Nominees at the 2023-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-09
  source text: Proposal 1 - Election of Class II and Class III Director Nominees The stockholders of the Company elected Georges Gemayel, Ph.D., Mark Chin, MS, MBA, and Liam Ratcliffe, M.D., Ph.D. as Class II directors of the Company, for a two-year term ending at the annual meeting of stockholders to be held in 2025 and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the Class II directors were as follows: Name Votes For Votes Withheld Broker Non-Votes Georges Gemayel, Ph.D. 13,073,343 16,929 980,030 Mark Chin, MS, MBA 13,073,267 17,005 980,030 Liam Ratcliffe, M.D., Ph.D. 13,081,593 8,679 980,030 The stockholders of the Company elected Donald Nicholson, Ph.D., William White, MPP, J.D., and John Quisel, J.D., Ph.D. as Class III directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2026 and until their successors h
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/0001193125-23-164532-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.